SAN DANIELE DEL FRIULI, Italy, March 14, 2017 /PRNewswire/ --
Lima Corporate is celebrating the 10th anniversary of Trabecular Titanium (TT), Lima's proprietary 3D printing technology. This anniversary positions Lima as the pioneer and leading company for 3D printing technologies applied to orthopaedics.
The decision made by Lima Corporate to develop EBM (Electron Beam Melting) technology, or additive manufacturing, was made to help address the functional limits of the coatings applied to traditional prosthetic implants. Lima decided to strengthen a partnership with Arcam to further develop the potential of the TT technology by using Arcam's knowledge and experience with 3D printing in other industries.
"We are very proud to support Lima on their impressive additive manufacturing journey. As a pioneer of additive manufacturing, Lima has taken the lead in transforming the orthopaedic industry and thereby transforming Arcam," said Magnus Rene, CEO of Arcam.
"Lima is instrumental in Arcam's development as a major supplier of EBM-based manufacturing equipment and metal powders for additive manufacturing in orthopaedics."
As a result of this partnership, Lima began with the acquisition of the first machines and the production of prototypes to study the effects of a material that could potentially mimic trabecular bone.
This experience with Trabecular Titanium highlighted the impressive versatility of the technology. The geometries that can be produced with EBM technology immediately revealed that the new material exceeded the limits of traditional machining production processes.
In 2007, the first acetabular cup, the Lima Delta TT Cup, was born with the objective to satisfy the demands of surgeons for better implant performance and outcomes; after obtaining the CE mark, the Delta TT Cup was implanted for the first time in Italy and since then it has been available in the global market. Following this experience over the past 10 years, Lima has developed a product portfolio covering different anatomical areas from hip to extremities as well as tailored solutions for patient-specific needs utilizing TT.
"Lima is known for innovation and our focus on pre-clinical and clinical research to support innovation. This milestone is a great recognition for Lima and our supporting surgeons that believed in this technology 10 years ago and have continued this exciting path with us. From this innovation to many others, Lima will continue to grow and develop solutions to assist orthopaedic surgeons in restarting the emotion of motion," said Mr. Luigi Ferrari, Lima Corporate CEO.
About Lima Corporate
Lima Corporate is a global medical device company providing reconstructive orthopaedic solutions to surgeons who face the challenges of improving the quality of life of their patients. Based in Italy, Lima Corporate is committed to the development of innovative products and procedures to enable surgeons to select ideal solution for every individual patient. Lima Corporate's product range includes large joint revision and primary implants and complete extremities solutions including fixation.
For additional information on the Company, please visit http://www.limacorporate.com.
https://www.limacorporate.com/repo/transfers/13/Lima_Corporate_Press_Release_TT_FINAL_EN_ITA.pdf
Limacorporate spa
Via Nazionale, 52
33038 Villanova di San Daniele
Udine - Italy
t: +39-0432-945511
e.: info@limacorporate.com
http://www.limacorporate.com
